DNA

#3010
Ginkgo Bioworks Holdings, Inc.
7.7250 USD
+16.34%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
7.5600
7.7400
Intervallo Annuale
5.3700
9.7200
Variazione giornaliera
+16.34%
Variazione Mensile
+10.36%
Variazione di 6 mesi
-13.01%
Variazione Annuale
-13.01%
Chiusura Precedente
6.6400
Apertura
7.5600
Bid
Ask
Minimo
7.5600
High
7.7400
Volume
495
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 20212022202320242025 TTM

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Notizie